Bionure


Bionure is a late-preclinical company focused at developing First-in-Class SGK agonists for the treatment of rare ophthalmology diseases.

Employees

1-10

Links


Org chart

Carmen Sanfrancisco
CEO - Consejera delegada
Collapse
Ricard Mis
Scientific Director

Teams

This company has no teams yet


Offices